Vascular Neoplasms With NFATC1/C2 Gene Alterations: Expanding the Clinicopathologic and Molecular Characteristics of a Distinct Entity

*Department of Pathology and Laboratory Medicine Dartmouth Health

†Geisel School of Medicine at Dartmouth, Lebanon, NH

‡Department of Biopathology, Institut Bergonié, Comprehensive Cancer Center

§Bordeaux Institute of Oncology, BRIC, INSERM, Bordeaux University, Bergonié Institute, Bordeaux, France

∥Cedars Sinai Medical Center, Los Angeles, CA

¶University of Pittsburgh Medical Center, Shadyside, Pittsburgh, PA

#Biopticka Laboratory, Pilsen, Czech Republic

**Department of Pathology, Charles University, Faculty of Medicine in Plzen, Czech Republic

††Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH

‡‡Department of Pathology and Lab Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY

This study was supported in part by P50 CA217694 (C.R.A.), P30 CA008748 (C.R.A.), Kristin Ann Carr Foundation (C.R.A.), Cycle for Survival (C.R.A.), EHE Foundation (C.R.A.), Ken Pribil Foundation (C.R.A.).

Conflicts of Interest and Source of Funding: The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.

Correspondence: Cristina R. Antonescu, MD, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021 (e-mail: [email protected]).

Supplemental Digital Content is available for this article. Direct URL citations are provided in the HTML and PDF versions of this article on the journal's website, www.ajsp.com.

留言 (0)

沒有登入
gif